Literature DB >> 28660308

Relationship between RAGE gene polymorphisms and cardiovascular disease prognosis in the Chinese Han population.

Jinxiong Gao1,2, Liehua Deng1, Ying Wang2, Yanke Shi2, Xiaohua Xiao2, Xueou Zheng1, Hao Ren3, Dingli Xu4.   

Abstract

Cardiovascular disease (CVD) is the leading cause of death in China. This study aimed to investigate whether RAGE gene polymorphisms are associated with the prognosis of various cardiovascular diseases in the Chinese Han population. This study was conducted from July 2004 to December 2005 and a total of 425 subjects from Guangdong province were enrolled. Genotyping of the three polymorphisms (-429T/C, 1704G/T, and G82S) in the RAGE gene was performed with polymerase chain reaction/restriction fragment length polymorphism (PCR-RFLP). Patients were followed for 6.5 years to watch for the development of cardiovascular events and mortality. Subjects with the S mutation of the G82S polymorphism had a significantly higher risk of all-cause mortality and acute myocardial infarction (AMI) than did those with wild-type homozygosity. Logistic regression analysis and Kaplan-Meier analysis all revealed that the G82S polymorphism of the RAGE gene was associated with a significantly increased risk of all-cause mortality and AMI. However, the -429T/C and 1704G/T polymorphisms were not shown to have any effect on prognosis. In conclusion, the G82S variant of the RAGE gene was significantly associated with an increased risk of all-cause mortality and AMI in the Chinese Han population.

Entities:  

Keywords:  Coronary artery disease; Hypertension; Polymorphism; Prognosis; RAGE

Mesh:

Substances:

Year:  2017        PMID: 28660308     DOI: 10.1007/s00438-017-1341-1

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  21 in total

1.  Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.

Authors:  Yangsoo Jang; Ji Young Kim; Seok-Min Kang; Jung-Sun Kim; Jey Sook Chae; Oh Yoen Kim; Soo Jeong Koh; Hyun Chul Lee; Chul Woo Ahn; Young Duk Song; Jong Ho Lee
Journal:  Metabolism       Date:  2007-02       Impact factor: 8.694

Review 2.  Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.

Authors:  Ravichandran Ramasamy; Susan J Vannucci; Shirley Shi Du Yan; Kevan Herold; Shi Fang Yan; Ann Marie Schmidt
Journal:  Glycobiology       Date:  2005-03-10       Impact factor: 4.313

3.  Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients.

Authors:  Marta Kalousová; Marie Jáchymová; Alexandra Germanová; Ales Antonín Kubena; Vladimír Tesar; Tomás Zima
Journal:  Kidney Blood Press Res       Date:  2010-02-23       Impact factor: 2.687

Review 4.  RAGE: a novel target for drug intervention in diabetic vascular disease.

Authors:  Barry I Hudson; Ann Marie Schmidt
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

5.  Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy.

Authors:  Suganthalakshmi Balasubbu; Periasamy Sundaresan; Anand Rajendran; Kim Ramasamy; Gowthaman Govindarajan; Namperumalsamy Perumalsamy; J Fielding Hejtmancik
Journal:  BMC Med Genet       Date:  2010-11-10       Impact factor: 2.103

6.  The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.

Authors:  Francesco Cipollone; Annalisa Iezzi; Maria Fazia; Mirco Zucchelli; Barbara Pini; Chiara Cuccurullo; Domenico De Cesare; Giovanni De Blasis; Raffaella Muraro; Roberto Bei; Francesco Chiarelli; Ann Marie Schmidt; Franco Cuccurullo; Andrea Mezzetti
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

Review 7.  Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Yoshifumi Naka; Ann Marie Schmidt
Journal:  Circ Res       Date:  2003-12-12       Impact factor: 17.367

8.  RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response.

Authors:  M A Hofmann; S Drury; B I Hudson; M R Gleason; W Qu; Y Lu; E Lalla; S Chitnis; J Monteiro; M H Stickland; L G Bucciarelli; B Moser; G Moxley; S Itescu; P J Grant; P K Gregersen; D M Stern; A M Schmidt
Journal:  Genes Immun       Date:  2002-05       Impact factor: 2.676

9.  Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients.

Authors:  Lin Lu; Li Jin Pu; Qiu Jing Chen; Linjie Wang; Wenhui Peng; Xiaoxiang Yan; Qi Zhang; Rui Yan Zhang; Pei Hua Gong; Jian Ping Qiu; Wei Feng Shen
Journal:  Clin Chim Acta       Date:  2008-06-26       Impact factor: 3.786

10.  Relation between polymorphisms of receptor for advanced glycation end products (RAGE) and cardiovascular diseases in Chinese patients with diabetic nephropathy.

Authors:  P Y-K Poon; C-C Szeto; K-M Chow; B C-H Kwan; P K-T Li
Journal:  Clin Nephrol       Date:  2010-01       Impact factor: 0.975

View more
  1 in total

Review 1.  Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models.

Authors:  Lander Egaña-Gorroño; Raquel López-Díez; Gautham Yepuri; Lisa S Ramirez; Sergey Reverdatto; Paul F Gugger; Alexander Shekhtman; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Front Cardiovasc Med       Date:  2020-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.